Clin. Breast Cancer 2019 Nov 21
Metastatic Presentations of Previously Treated Early-Stage Breast Cancer Patients and Association With Survival.
Itani N, Grogan N, Mott S, Phadke S
Breast cancer (BC) patients undergoing surveillance often fear recurrence. Given that routine imaging is not recommended, recognizing metastatic disea ...
Read More
Source: PubMed
Oncogene 2020 Jan 31
A role for CBFß in maintaining the metastatic phenotype of breast cancer cells.
Ran R, Harrison H, Syamimi Ariffin N, Ayub R, Pegg HJ, Deng W, Mastro A, Ottewell PD, Mason SM, Blyth K, Holen I, Shore P
Epithelial to mesenchymal transition (EMT) is a dynamic process that drives cancer cell plasticity and is thought to play a major role in metastasis. ...
Read More
Source: PubMed
Sci Rep
Author Correction: Cancer Testis Antigen Promotes Triple Negative Breast Cancer Metastasis and is Traceable in the Circulating Extracellular Vesicles.
Kannan A, Philley JV, Hertweck KL, Ndetan H, Singh KP, Sivakumar S, Wells RB, Vadlamudi RK, Dasgupta S
An amendment to this paper has been published and can be accessed via a link at the top of the paper. ...
Read More
Source: PubMed
Clin. Cancer Res. 2020 Jan 31
Predictive biomarkers for adjuvant capecitabine benefit in early stage triple negative breast cancer in the FinXX clinical trial.
Asleh K, Brauer HA, Sullivan A, Lauttia S, Lindman H, Nielsen TO, Joensuu H, Thompson EA, Chumsri S
Recent studies have demonstrated a benefit of adjuvant capecitabine in early breast cancer, particularly in patients with triple negative breast cance ...
Read More
Source: PubMed
Pathol. Res. Pract. 2019 Dec 24
PD-L1 expression in tumor infiltrated lymphocytes predicts survival in triple-negative breast cancer.
Wang X, Liu Y
Triple-negative breast cancer (TNBC), a complex and highly aggressive subtype of breast cancer, generally has the poorest clinical outcome, there is a ...
Read More
Source: PubMed